HemoGenyx Readies for AML Trial with New Assay - TipRanks
HOPHF Stock | USD 0 0.00 0.00% |
Roughly 56% of Hemogenyx Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Hemogenyx Pharmaceuticals Plc pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Hemogenyx Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Hemogenyx Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Hemogenyx Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hemogenyx daily returns and investor perception about the current price of Hemogenyx Pharmaceuticals Plc as well as its diversification or hedging effects on your existing portfolios.
Hemogenyx |
HemoGenyx Readies for AML Trial with New Assay TipRanks
Read at news.google.com
Hemogenyx Pharmaceuticals Fundamental Analysis
We analyze Hemogenyx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Hemogenyx Pharmaceuticals is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Hemogenyx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hemogenyx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Hemogenyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Hemogenyx Pharmaceuticals Related Equities
SNTI | Senti Biosciences | 3.65 | ||||
MNPR | Monopar Therapeutics | 1.24 | ||||
GNLX | Genelux Common | 0.00 | ||||
FHTX | Foghorn Therapeutics | 0.00 | ||||
FENC | Fennec Pharmaceuticals | 0.33 | ||||
CVKD | Cadrenal Therapeutics, | 0.71 | ||||
INBX | Inhibrx | 0.79 | ||||
CING | Cingulate | 1.15 | ||||
ELYM | Eliem Therapeutics | 1.90 | ||||
CELC | Celcuity LLC | 2.49 | ||||
DYAI | Dyadic International | 3.03 | ||||
PMN | ProMIS Neurosciences | 4.95 | ||||
QNRX | Quoin Pharmaceuticals | 6.05 | ||||
ELVN | Enliven Therapeutics | 8.43 | ||||
CCCC | C4 Therapeutics | 8.92 | ||||
GLUE | Monte Rosa | 9.52 | ||||
PRLD | Prelude Therapeutics | 9.82 | ||||
STTK | Shattuck Labs | 10.53 |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |